Brief: United Therapeutics And Intermountain Health Announce The First Patient Treated With External Liver Support Using A Bioengineered Liver
24/06/2025 12:10
June 24 (Reuters) - United Therapeutics Corp UTHR.O: UNITED THERAPEUTICS AND INTERMOUNTAIN HEALTH ANNOUNCE THE FIRST PATIENT TREATED WITH EXTERNAL LIVER SUPPORT USING A BIOENGINEERED LIVER Source text: ID:nBw9d5MHha Further company coverage: UTHR.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on United Therapeutics
See all newsBrief: United Therapeutics Corporation Announces Additional $2 Billion Share Repurchase Authorization
Brief: United Therapeutics Announces FDA Clearance To Proceed With Summit Clinical Trial For Treprostinil Smi In Ph-Copd
Liquidia surges as United Therapeutics settlement removes key litigation risk (updated)
Brief: United Therapeutics Enters Settlement Agreement With Liquidia To Resolve Litigation - SEC Filing
Liquidia surges after $381 million settlement with United Therapeutics for lung disease drug